These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25183006)

  • 1. Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation.
    Vigetti D; Deleonibus S; Moretto P; Bowen T; Fischer JW; Grandoch M; Oberhuber A; Love DC; Hanover JA; Cinquetti R; Karousou E; Viola M; D'Angelo ML; Hascall VC; De Luca G; Passi A
    J Biol Chem; 2014 Oct; 289(42):28816-26. PubMed ID: 25183006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.
    Vigetti D; Deleonibus S; Moretto P; Karousou E; Viola M; Bartolini B; Hascall VC; Tammi M; De Luca G; Passi A
    J Biol Chem; 2012 Oct; 287(42):35544-35555. PubMed ID: 22887999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-κB and expression of the long-noncoding RNA HAS2-AS1.
    Caon I; Bartolini B; Moretto P; Parnigoni A; Caravà E; Vitale DL; Alaniz L; Viola M; Karousou E; De Luca G; Hascall VC; Passi A; Vigetti D
    J Biol Chem; 2020 Mar; 295(11):3485-3496. PubMed ID: 31932306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1.
    Jokela TA; Makkonen KM; Oikari S; Kärnä R; Koli E; Hart GW; Tammi RH; Carlberg C; Tammi MI
    J Biol Chem; 2011 Sep; 286(38):33632-40. PubMed ID: 21795679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell.
    Michael DR; Phillips AO; Krupa A; Martin J; Redman JE; Altaher A; Neville RD; Webber J; Kim MY; Bowen T
    J Biol Chem; 2011 Jun; 286(22):19523-32. PubMed ID: 21357421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the multifaceted long non-coding RNAs: A nuclear-cytosolic interplay to regulate hyaluronan metabolism.
    Parnigoni A; Caon I; Moretto P; Viola M; Karousou E; Passi A; Vigetti D
    Matrix Biol Plus; 2021 Aug; 11():100060. PubMed ID: 34435179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Energy Metabolism and Hyaluronan Synthesis.
    Caon I; Parnigoni A; Viola M; Karousou E; Passi A; Vigetti D
    J Histochem Cytochem; 2021 Jan; 69(1):35-47. PubMed ID: 32623953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated Hyaluronan Synthesis by Vascular Cells.
    Viola M; Karousou E; D'Angelo ML; Caon I; De Luca G; Passi A; Vigetti D
    Int J Cell Biol; 2015; 2015():208303. PubMed ID: 26448750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
    Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
    Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control of hyaluronan synthases.
    Vigetti D; Viola M; Karousou E; De Luca G; Passi A
    Matrix Biol; 2014 Apr; 35():8-13. PubMed ID: 24134926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.
    Rilla K; Oikari S; Jokela TA; Hyttinen JM; Kärnä R; Tammi RH; Tammi MI
    J Biol Chem; 2013 Feb; 288(8):5973-83. PubMed ID: 23303191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undetectable histone O-GlcNAcylation in mammalian cells.
    Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
    Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cells.
    Xing D; Gong K; Feng W; Nozell SE; Chen YF; Chatham JC; Oparil S
    PLoS One; 2011; 6(8):e24021. PubMed ID: 21904602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation.
    Akimoto Y; Kreppel LK; Hirano H; Hart GW
    Arch Biochem Biophys; 2001 May; 389(2):166-75. PubMed ID: 11339805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
    Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
    Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation.
    Chao H; Spicer AP
    J Biol Chem; 2005 Jul; 280(30):27513-22. PubMed ID: 15843373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mutations in the post-translational modification sites on the trafficking of hyaluronan synthase 2 (HAS2).
    Melero-Fernandez de Mera RM; Arasu UT; Kärnä R; Oikari S; Rilla K; Vigetti D; Passi A; Heldin P; Tammi MI; Deen AJ
    Matrix Biol; 2019 Jul; 80():85-103. PubMed ID: 30394292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.